产品详情
所在位置: 首页> 产品目录> 试剂>
  • 产品名称:Retigabine

  • 产品型号:
  • 产品厂商:TargetMol
  • 产品文档:
你添加了1件商品 查看购物车
简单介绍:
Retigabine
详情介绍:
Purpose Ezogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in ***** patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine.
Characteristics Target: Potassium Channel
Receptor: Potassium Channel
Purification All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
Purity 98 %
Formula C16H18FN3O2
Solubility 10 mM in DMSO
Molecular Weight 303.33 g/mol
CAS-No 150812-12-7
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Solid
Storage -20 °C
Storage Comment For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
Expiry Date 24 months